Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
Description
Patients with inflammatory bowel disease (IBD) treated with biologic and/or immunosuppressant drugs are at increased risk for opportunistic infections. Seroprevalence studies can confirm the diagnosis of SARS-CoV-2 infections as well as the